| Financial Year |
March 31 2023 |
| Monetary Funds |
388,289,848.26 |
| Held-for-trading Financial Assets |
280,286,000.00 |
| Notes Receivable |
1,140,000.00 |
| Accounts Receivable |
225,408,050.03 |
| Advances to Suppliers |
9,279,547.73 |
| Other Receivables |
18,201,796.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
326,159,275.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
126,298,848.68 |
| Total Current Assets |
1,375,063,367.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,909,341.20 |
| Investment Properties |
-- |
| Fixed Assetes |
64,095,158.50 |
| Under-construction Projects |
1,500,028.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,377,738.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,711,099.39 |
| Deferred Income Tax Assets |
28,590,435.38 |
| Other Non-Current Assets |
195,692,424.61 |
| Sub-Total of Non-Current Assets |
723,043,960.71 |
| Total Assets |
2,098,107,327.86 |
| Short-Term Loans |
320,283,555.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,600,000.00 |
| Accounts Payable |
319,685,901.15 |
| Accounts Received In Advance |
600,828.06 |
| Employee Compensation Payable |
21,702,458.02 |
| Taxes Payable |
8,852,686.34 |
| Interest Payable |
-- |
| Dividend Payable |
2,207,127.29 |
| Other payables |
90,100,375.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,674,578.72 |
| Other Current Liabilities |
11,983,800.94 |
| Sub-Total of Current Liabilities |
941,667,268.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
59,214,433.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
153,917,695.64 |
| Total Liabilities |
1,095,584,963.71 |
| Paid-In Capital(Or Share Stock) |
223,086,347.00 |
| Capital Surplus |
65,189,347.33 |
| Surplus Reserve |
61,754,430.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
467,037,324.06 |
| Minority Stockholder's Interest |
7,007,315.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
995,515,048.26 |
| Owner's Equity（Stockholder's Equity） |
1,002,522,364.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,098,107,327.86 |
